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Abstract
Purpose Cancer-induced muscle wasting (i.e., cancer cachexia, CC) is a common and devastating syndrome that results in
the death of more than 1 in 5 patients. Although primarily a result of elevated inflammation, there are multiple mechanisms
that complement and amplify one another. Research on the use of exercise to manage CC is still limited, while exercise for CC
management has been recently discouraged. Moreover, there is a lack of understanding that exercise is not a single medicine,
but mode, type, dosage, and timing (exercise prescription) have distinct health outcomes. The purpose of this review was to
examine the effects of these modes and subtypes to identify the most optimal form and dosage of exercise therapy specific
to each underlying mechanism of CC.
Methods The relevant literatures from MEDLINE and Scopus databases were examined.
Results Exercise can counteract the most prominent mechanisms and signs of CC including muscle wasting, increased protein turnover, systemic inflammation, reduced appetite and anorexia, increased energy expenditure and fat wasting, insulin
resistance, metabolic dysregulation, gut dysbiosis, hypogonadism, impaired oxidative capacity, mitochondrial dysfunction,
and cancer treatments side-effects. There are different modes of exercise, and each mode has different sub-types that induce
vastly diverse changes when performed over multiple sessions. Choosing suboptimal exercise modes, types, or dosages can
be counterproductive and could further contribute to the mechanisms of CC without impacting muscle growth.
Conclusion Available evidence shows that patients with CC can safely undertake higher-intensity resistance exercise programs, and benefit from increases in body mass and muscle mass.
Keywords Cancer cachexia · Inflammation · Tumor · Exercise · Muscle wasting · Muscle atrophy
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Abbreviations
CC	Cancer cachexia
CRP	C-reactive protein
HIIET	Higher-intensity interval endurance training
HOMA	Homeostasis model assessment
IGF-1	Insulin-like growth factor 1
LICET	Low-intensity continuous endurance training
mTORC1	MTOR complex 1
RET	Resistance exercise training
TNF-α	Tumor-necrosis factor alpha

Introduction
Among the most detrimental side effects of cancer and treatment is cachexia, a multifactorial metabolic and immune
system imbalance (Tisdale 2005). Cancer cachexia (CC) is
the ongoing skeletal muscle loss (with or without fat mass
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loss) during cancer manifestation and treatment, which cannot be reversed by conventional nutritional support, leading
to progressive functional impairment and death (Fearon et al.
2011). Half of all cancer patients develop cachexia, and this
estimate increases to 80% in hospitalized or advanced-stage
patients (Tisdale 2003). Cachexia is observed in 80% of gastric, pancreatic, and esophageal, ~ 70% of head-and-neck,
~ 60% of lung, colorectal, lymphoma, and prostate, and 54%
of malignant pleural mesothelioma cancer patients (Laviano
and Meguid 1996). Moreover, CC is the immediate cause
of death of at least 22% of all cancer patients (Argilés et al.
2014). Notably, aside from cancer, cachexia is observed in
the late stages of almost every major chronic illness (Farkas
et al. 2013), such as HIV/AIDS (prevalence 35%), chronic
heart failure and chronic obstructive pulmonary disease
(20%), chronic kidney disease (40%), and rheumatoid arthritis (10%) (von Haehling and Anker 2010). Despite the prevalence and severity, cachexia remains under-researched, while
treatment options are limited, due to treatment inadequacy
and inconsistency (Roeland et al. 2020).
CC progression is often described as a continuum,
advancing from pre-cachexia to cachexia, and finally to
refractory cachexia, where the expected survival is less
than 3 months (Fearon et al. 2011). Even though its pathologic mechanisms are complex (see Fig. 1), it is often mistakenly regarded as a uniform condition, with little understanding that the underlying causes can be heterogeneous.
Causes of CC can be malnutrition/anorexia (Fredrix et al.
1990), elevated inflammation (Tisdale 2005; Argilés et al.
2014), or even treatments such as chemotherapy (Brierley
et al. 2019). Due to the complexity and varying proportion
of underlying causes, a one-size-fits-all approach cannot
be assumed, and different treatment strategies must be
employed to counteract the patient’s mechanism profile.
While pharmacological interventions to reduce inflammation, stimulate appetite, or reduce muscle wasting
already exist (Saeteaw et al. 2020), these should ideally
be accompanied with adjunct non-pharmacological treatments, such as exercise, to amplify treatment effectiveness.
Awareness that exercise as a medicine can be effective
and reliable in cancer supportive care is well-established
(Schmitz et al. 2019); however, there is a lack of understanding that exercise is not a single medicine, but mode,
type, dosage, and timing (exercise prescription) have distinct effects on the components of health and fitness. For
example, resistance exercise training (RET) consists of
high-tension muscle contractions against a heavy external
load and when performed regularly and in sufficient volume leads to increased muscle mass and strength (Grgic
et al. 2019). On the other hand, endurance exercise consists of long durations of low-tension muscle contractions
which result in increased respiration, cardiac output,
and blood flow, leading to increased oxidative capacity,
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improved cardiovascular function, and fatigue resistance
(Egan and Zierath 2013). Therefore, the different exercise
modes will be reviewed to explore potential applications
of targeted exercise medicine for CC management.
Apart from different exercise modes, different types of each
mode can also elicit distinct and clinically-relevant outcomes.
For example, during RET, different contractions are performed, such as concentric, eccentric, and isometric. Eccentric
(lengthening) contractions are performed when the force generated by the muscle is less than the external load, causing the
muscle to lengthen while resisting the external load. In contrast, concentric (shortening) contractions in which the force
is greater than the load, allows the muscle to shorten (Vogt
and Hoppeler 2014). During exercise composed of eccentric
contractions (eccentric RET), the same muscle work can be
produced with only ~ 15% of the metabolic demand of equivalent concentric RET, which enables the performance of more
contractions for the same effort (Lastayo et al. 1999). Similarly in endurance training, due to cancer-related fatigue and
reduced physical capacity, non-continuous training (interval)
with short bursts of work and longer rests might be more tolerable than a single continuous effort. Moreover, higher-intensity
interval endurance training (HIIET) is as effective at increasing
muscle oxidative capacity as lower-intensity continuous endurance training (LICET) (Gibala and McGee 2008).
Recently, the American Society of Clinical Oncology
published their guideline on the management of CC and
concluded that exercise after the onset of CC is ineffective
(Roeland et al. 2020), and therefore not recommended. These
recommendations are particularly surprising, given that they
were based on no trials (Roeland et al. 2020). Even in animal
CC models, RET increases body (Donatto et al. 2013) and
muscle mass (Hardee et al. 2016). Moreover, RET trials in
cancer patients with particularly aggressive CC forms (e.g.,
pancreatic cancer) already exist (Table 1). Notably, RET did
not only preserve muscle mass in patients with pancreatic
and lung CC (Naito et al. 2019), but even increased body
(Wiskemann et al. 2019) and muscle mass (Kamel et al. 2020)
in patients with pancreatic CC, and increased muscle mass in
head and neck cancer patients undergoing radiotherapy with
large (> 8.5%) body mass loss (Lønbro et al. 2013a). Therefore, CC patients may experience clinically-significant muscle
mass and strength gains following supervised RET (Lønbro
et al. 2013a; Naito et al. 2019; Wiskemann et al. 2019; Kamel
et al. 2020). However, more trials are needed to examine the
most effective RET type, and the specific exercise parameters
(i.e., intensity, volume, time under tension) to simultaneously
increase muscle mass and reduce inflammation.
The purpose of this review is to examine the most prominent CC mechanisms, and provide a rationale for research
recommendations on specific exercise modes (and types) that
could be used as a targeted non-pharmacological therapy integrated with the patient’s clinical treatment plan to not only
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Fig. 1  Cachexia mechanisms. APR acute phase response, CRP
C-reactive protein, ECM extracellular matrix, IGF-1 insulin growth
factor 1, IL interleukin (1–11), INF-γ interferon gamma, LMF lipid-

mobilizing factor, PIF proteolysis-inducing factor, REE resting
energy expenditure, TGF-β transforming growth factor beta, TNF-α
tumor necrosis factor alpha

reduce the side effects of cancer treatments but also improve
their effectiveness, and reduce disease severity by reversing the
multiple physiological mechanisms driving CC.

Muscle mass is sustained by an intricate balance of protein
breakdown and synthesis, known as protein turnover. Muscle proteins are in a constant state of turnover to maintain
protein homeostasis, but CC disrupts this process, as there is
simultaneously excessive protein breakdown and suppressed
protein synthesis (White et al. 2013). Although increased
body mass is desirable during CC, it is more important for
the gained mass to be composed of muscle rather than fat.
Specifically, skeletal muscle is an important resource for

Muscle mass wasting and increased protein
turnover
The most devastating symptom of CC is muscle wasting,
which can result from a variety of mechanisms (Fig. 1).
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162 cancer patients

60 head and neck cancer patients
undergoing radiotherapy

151 patients with cancer cachexia

45 patients with inoperable lung
cancer

12 head and neck cancer patients
undergoing radiotherapy

Patients with pancreatic CC

21 head and neck cancer patients
undergoing radiotherapy

36 head and neck cancer patients
undergoing radiotherapy
Advanced pancreatic and lung cancer
scheduled for chemotherapy

Case-study of stage IV pancreatic
cancer patient undergoing chemotherapy

15 head and neck cancer patients
undergoing radiotherapy

Bland et al. (2021)

Capozzi et al. (2016)

Del Fabbro et al. (2011)

Denehy et al. (2020)

Grote et al. (2018)

Kamel et al. (2020)

Lønbro et al. (2013b)

Lønbro et al. (2013a)

Niels et al. (2018)

Rogers et al. (2013)

Naito et al. (2019)

Population

Study

Table 1  Exercise training trials involving humans with cancer cachexia

Stabilized BM between 6-week visits
to the clinic, improved physical function, pain, nausea, appetite, anorexiacachexia symptoms, physical,
emotional and functional wellbeing
The program failed to reduce loss of
lean BM (− 5 kg) but improved quality of life, depression, and nutritional
scores
Increased appetite and BM for those
who returned for a second visit

Multidisciplinary clinical service for
cancer cachexia; same as Vaughan
et al. (2020)

Dietary counseling by a dietician and
standard exercise recommendations
in an exercise clinic
6-week biweekly home-based LICET

12-week lifestyle intervention and
progressive RET

Outcomes

Intervention

Better physical strength in adherent
than non-adherent group, without differences in quality of life and disease
symptoms
BM loss (7.1%)
At least 13 sessions of RET (3 sets;
Increases in muscle strength but differ8–12 RM)
ence between groups in lean BM was
not significant (intervention: + 1%,
usual-care: − 3%)
BM loss > 5% over the past 6 months 12-week (2 week−1) whole-body RET Improvements in mobility, muscle
mass, and strength, of both upper(50–80% of the participant’s 1-RM;
and lower-limbs over a non-exercis3 sets; 8–12 repetitions)
ing group
5% increase in lean BM for the suppleLarge BM loss > 8.5% in 2 months
12-week (30 sessions) whole-body
mentation and 2.8% for the exerciseRET with or without creatine and
only group. Both increased strength
protein supplementation
Large BM loss > 8.5% in 2 months
12-week (30 sessions) whole-body
4.3% increase in lean BM and
RET (2–3 sets of 8–15 RM)
increased muscle strength
BM loss of > 5% during the preceding 8 weeks of nutritional counseling,
Body and skeletal muscle mass, and
6 months or > 2% in patients with a
muscle function were maintained
supplementation (branched-chain
BM index < 20 kg/m2; CC in 40%
amino acids, coenzyme Q10, and
L-carnitine) home-based bodyof patients
weight RET 3 sets of 10 repetitions
Typically expected 30% BM loss in
12-week biweekly RET (8–12 repeti- Maintained BM, increased strength
patient
tions and 2 sets with 70–80% of
rep-max), and LICET (70–80% of
maximum of watt) 16 min, 2 sets
Usual-care group lost 5.5 kg of lean
BM loss
12-week RET (exercise bands);
BM, while intervention group lost
6-week supervised; 6-week unsuonly 0.4
pervised

41% had CC

History of BM loss ≥ 5% (median
was 9%)

6-month BM loss at baseline was
10.4%; 7 (4%) patients had precachexia, 83 (51%) had cachexia,
and 29 (18%) had refractory
cachexia

Cachexia criteria

Journal of Cancer Research and Clinical Oncology

52 advanced cancer patients

99 cancer patients

65 patients with pancreatic cancer

Storck et al. (2020)

Vaughan et al. (2020)

Wiskemann et al. (2019)

BM body mass, CC cancer cachexia, LICET low-intensity continuous endurance training, RET resistance exercise training, RM repetition maximum

Even though only control group lost
BM index < 30 kg/m2; and < 20% BM 6 weeks of (a) anti-inflammatory
BM, both lost muscle mass
loss in the previous 6 months
medication, (b) EPA supplementation, (c) nutritional counseling, (d)
biweekly home-based LICET and
RET
12-week leucine-rich supplementaIncreases in lean BM did not reach
tion, nutrition, and exercise program significance vs usual-care. Increases
in handgrip strength, trend for
improvement in nutritional status,
dietary intake, fatigue, quality of life
and clinical course
6-week home-based RET (5 exer6% of patients were pre-cachectic
49% displayed positive outcomes with
cises; ~ 4 week−1), high energy and
(BM loss < 5%), 64% were cachec> 2-kg BM gain between two contic (BM loss ≥ 5% or BMI < 20 with protein diets, supplementation of
secutive appointments, 54% increased
BM loss > 2%, systemic inflammid-upper arm muscle circumferfish oil, zinc, and multi-vitamins
mation), and 30% had refractory
ence, and > 50% improved functional
cachexia (survival < 90 days, BM
strength between two consecutive
loss ≥ 5% or BMI < 20 with weight
appointments
loss > 2%)
Half of the patients had BM loss
6-months (2 week−1) whole-body
Higher adherence when home-based
(≥ 10% in last 6 months)
(78.4%) versus clinic-based (64.1%),
RET either at home or performed
but only the clinic-based group
under supervision in an exercise
significantly increased upper- and
clinic (50–80% of 1-RM, 3 sets;
lower-body strength, and BM (3.1%)
8–12 repetitions)
over a non-exercising group

Pancreatic or lung cancer commencing chemotherapy

Outcomes

Kaasa et al. (2015), Solheim
et al. (2017), Balstad et al.
(2020)

Intervention

Cachexia criteria

Population

Study

Table 1  (continued)
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cancer patients, not only for metabolic, hormonal, and physical capacity reasons, but also because low muscle mass significantly predicts chemotherapy-induced toxicity and survival (Pin et al. 2018).
It is well established from a variety of studies that RET
stimulates myofibrillar protein synthesis, whereas endurance training stimulates mitochondrial synthesis (Grgic et al.
2019). Consequently, endurance exercise training does not
promote the same degree of skeletal muscle hypertrophy as
RET (Grgic et al. 2019). However, recent reviews on exercise during CC have surprisingly recommended endurance
over RET for preventing muscle wasting during CC (Aquila
et al. 2020). In fact, when performing LICET concurrently
with RET, it can result in smaller muscle growth compared
to RET alone due to physiological interference (Wilson et al.
2012). For example, we have reported that prostate cancer
patients who underwent androgen-deprivation therapy and
RET, had greater increases in appendicular muscle mass
versus those that included additional 20–30 min of LICET
(Newton et al. 2019). Nevertheless, studies with preclinical
models showed that endurance exercise might prevent muscle loss (Jee et al. 2016), however, only the mice undergoing higher-intensity activity (90% of maximum heart rate,
every second day exercise for 45 min) preserved their muscle weight, while moderate intensities (70% of maximum
heart rate) did not elicit the same effects (Jee et al. 2016).
Moreover, lack of adequate intensity could have led to null
findings in a study where patients with lung and pancreatic
CC undergoing radiotherapy underwent 6-weeks of homebased exercise and supplementation (Solheim et al. 2017).
The program consisted of twice-weekly LICET (30 min) and
thrice-weekly RET, however, the exercises performed were
of very light loads, such as body-weight pushups against
the wall, and failed to significantly reduce muscle wasting
(Solheim et al. 2017). Overall, current evidence suggests
that heavier muscle loading is preferable and likely to be
essential for hypertrophy.
During CC, metabolic and signaling pathways that
increase protein synthesis are suppressed while pathways
that decrease protein synthesis are activated, with this
phenomenon considered the primary mechanism for muscle wasting (Tisdale 2009). Specifically, type II myofiber
atrophy is particularly prevalent during CC, occurring to a
greater degree than type I myofiber atrophy (Mendell and
Engel 1971). Moreover, it is well-established that mTOR
complex 1 (mTORC1) plays a central role in mechanical
load-induced muscle growth by activating downstream
substrates such as p70S6k, which is an integral pathway
for muscle protein synthesis (Goodman et al. 2011). This
pathway is regulated by signaling molecules such as insulin-like growth factor 1 (IGF-1), which is progressively
decreased in tissue and blood during CC (White et al. 2013;
Martins et al. 2018). However, it appears that this problem
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is multi-faceted, as exogenous IGF-1 treatment does not
attenuate CC-induced muscle wasting (Costelli et al. 2006).
Additionally, pathways that suppress protein synthesis, such
as those involving AMPK, FoxO, STAT3, and myostatin are
up-regulated during CC (White et al. 2013; Hardee et al.
2016, 2020). Previous investigations showed that eccentric
RET stimulates pathways commonly affected during CC
that cause muscle hypertrophy (IGF-1, mTORC1, p70S6k)
and suppressed pathways that cause atrophy (FoxO, AMPK,
STAT3, MuRF-1, myostatin) (Hardee et al. 2016, 2020;
Tatebayashi et al. 2018; Martins et al. 2018), and those
effects are often greater compared to equivalent concentric
RET. Additionally, greater increases in type II myofiber
size are observed from eccentric compared to concentric
or even conventional RET (both concentric + eccentric),
at least in healthy humans (Hather et al. 1991; Hortobágyi
et al. 1996, 2000; Friedmann et al. 2004; Friedmann-Bette
et al. 2010; English et al. 2014; Horwath et al. 2019). CC
reduces muscle protein synthesis, partially through elevated
IL-6 (Tisdale 2005; Argilés et al. 2014). Nevertheless, 14
sessions of maximal eccentric RET effectively increased
protein synthesis (p70S6K and rpS6), reversed inhibitors of
protein synthesis (MuRF-1), and reduced the CC-induced
atrophy in mouse gastrocnemius (Tatebayashi et al. 2018).
This was also verified by another group, as eight sessions
of maximal eccentric RET improved oxidative metabolism,
reduced muscle wasting, and increased basal muscle protein
synthesis and mTORC1, and surprisingly, these improvements were positively correlated with plasma IL-6 levels
(Hardee et al. 2020). These findings have significant implications for clinical practice due to the potential of repeated
RET (particularly eccentric) in ‘exploiting’ elevated inflammation to proportionately increase muscle growth (see also
“Systemic inflammation”).
Apart from signaling factor changes, CC can induce
long-term muscle composition changes. For example, in
mice with CC, muscle non-contractile tissue (fibrosis) was
~ 2.1-fold greater compared to healthy controls, but 2 weeks
(4 week−1) of eccentric RET reduced fibrosis by 20% (Hardee et al. 2016). Another muscle-wasting mechanism during CC is dystrophin loss without an inherent genetic issue,
leading to myofiber integrity impairments, muscle protein
breakdown and wasting (Acharyya et al. 2005). In contrast,
increased muscle integrin concentration can compensate
for the lack of dystrophin in dystrophic animals by maintaining muscle mobility and structure and increasing muscle mass (Burkin et al. 2005). Integrin concentrations in
humans increase after long-term eccentric RET (Mavropalias et al. 2021b), but there is a lack of information regarding
the effects of concentric RET. We have recently reported
that 20–30 min of eccentric RET per week elicited large
increases (in some cases > 30%) in muscle cross-sectional
area in healthy men after only 8 weeks (Mavropalias et al.
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2021b). Given that integrins sense mechanical tension and
stimulate protein synthesis, increased integrin concentration
following eccentric RET could enhance anabolic signaling,
thereby further amplifying muscle growth (Burkin et al.
2005).
Thus, eccentric RET appears to be specific and potent for
counteracting the multiple causes of wasting at the myofiber
level and could be very beneficial if incorporated as an additional brief component after a conventional RET program.

Systemic inflammation
Persistently elevated circulating levels of interleukins,
C-reactive protein (CRP), tumor-necrosis factor alpha (TNFα), and interferon-γ are hallmark indicators and primary
drivers of CC (Tisdale 2005; Argilés et al. 2009, 2014).
These tumor-driven cytokines cause multiple health issues,
such as anorexia, and increased metabolic rate, lipolysis,
and proteolysis, among others (Tisdale 2005; Argilés et al.
2009, 2014). Therefore, controlling systemic inflammation
is critical for CC prevention and management.
Exercise is generally thought to induce a pro-inflammatory state for a few hours following a session and thus may
seem contra-indicated in the presence of already exacerbated
inflammation. However, pro-inflammatory cytokines, such
as TNF-α and interleukin-1, do not markedly increase after
exercise, suggesting that the exercise-induced inflammatory
profile differs from that induced by disease. In fact, musclederived IL-6 following exercise may inhibit the effects of
pro-inflammatory cytokines such as TNF-α (Pedersen et al.
2001). Therefore, acute (a few hours post-exercise) exercise-induced increases in cytokine levels do not exacerbate
already high-inflammation states but may instead exert an
inflammation-controlling effect.
IL-6 is a critical cytokine for muscle metabolism, as it
mediates muscle growth demonstrated by both in-vivo and
in-vitro studies (Serrano et al. 2008). However, when chronically elevated, circulating IL-6 negatively correlates with
myofiber cross-sectional area and protein synthesis (Hardee et al. 2020). Exercise training can lower elevated IL-6,
as 12 weeks (3 week−1) of either descending or ascending stair-walking in women decreased resting IL-6 levels
(− 24%) (Chow et al. 2020). In pre-clinical CC models,
muscle growth induced by 2 weeks (4 week−1) of eccentric
RET positively correlated with circulating IL-6 (Hardee
et al. 2020), such that higher serum IL-6 was associated
with greater muscle protein synthesis. This suggests that
in mice with CC, repeated eccentric RET might mediate
muscle protein synthesis through inflammation (greater
inflammation induces greater muscle protein synthesis), a
finding which may hold potential for CC patients. It is currently unknown if this effect is induced by concentric or
conventional RET, however, based on its ability to control

IL-6 in healthy women (Chow et al. 2020), pathways that
mediate protein synthesis through elevated IL-6 might also
be activated during concentric RET.
CRP is the most practical, cost-effective, and scientifically robust CC biomarker, with important roles in prognosis, and utility to predict quality of life in CC patients
(Fearon et al. 2011; Laird et al. 2016). The results of one
meta-analysis were that RET reduces CRP levels, but only
when the programs included more than eight exercises, were
performed at least 3 week−1, and for longer than 12 weeks
(Sardeli et al. 2018). However, 1 year of biweekly RET was
also effective in reducing CRP levels by ~ 10% in women
(Olson et al. 2007). Regarding type, RET either with eccentric or concentric movements reduced CRP levels (25%) in
sedentary humans, however, the authors reported that eccentric RET was significantly more efficient (~ 2.5 times) than
concentric after adjusting for energy expenditure (Zeppetzauer et al. 2013). Specifically for cancer, a meta-analysis
showed that a combination of RET and endurance training
can reduce CRP levels (Khosravi et al. 2019). Regarding
endurance exercise, patients with different cancer types had
a 6% reduction in CRP levels after 12 weeks (3 week−1)
of HIIET, but this was significantly different to the LICET
group who exhibited a 19% increase (Toohey et al. 2016).
These findings show a clear beneficial effect of RET of all
types in reducing CRP levels in both healthy and cancer
patients, however, there appears to be a preference for HIIET
over LICET in cancer patients, although the information at
this stage is limited.
Chronically elevated TNF-α, both circulating and in
muscle, is a common symptom during CC, and has been
also shown to be inversely associated with muscle protein
synthesis (Greiwe et al. 2001; Argilés et al. 2009, 2014).
However, 3 months (3 week−1) of lower-body RET was
effective in reducing TNF-α levels in the muscle of frail
elderly individuals (Greiwe et al. 2001). In another study,
12 weeks (3 week−1) of descending stair walking (eccentric
exercise for knee extensors) was more effective (− 40%)
than ascending stair walking training (− 24%) at decreasing
TNF-α levels in women (Chow et al. 2020). While research
on humans is limited, non-RET endurance training can precipitate decreased TNF-α levels, however, intensity matters,
as 8 weeks (5 week−1) of HIIET was more effective than
LICET in reducing TNF-α in mouse renal tissue (Leite et al.
2021).
Elevated circulating interferon-γ is another commonlyobserved disease sign during CC (Argilés et al. 2009).
Interferon-γ is produced by activated T and natural killer
cells, and animal studies have shown that increased
interferon-γ production rapidly develops CC, and that CC
can be reversed by blocking interferon-γ (Argilés et al.
2009). In elderly women, 12 weeks (3 week−1) of wholebody light-load (elastic bands) RET reduced interferon-γ
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levels (12%) (Roh et al. 2020). Moreover, patients with prostate cancer decreased interferon-γ levels after only 8 weeks
(3 week−1) of RET (Papadopoulos et al. 2021). Although
further information regarding responses to long-term exercise training is currently limited, these results are promising and suggest that even light-load RET might effectively
reduce interferon-γ levels.
Therefore, RET appears to be effective in reducing
elevated TNF-α, CRP, and interferon-γ, while simultaneously ‘exploiting’ elevated IL-6, typically observed during
CC, to increase muscle protein synthesis. When combined
with HIIET, the inflammation-controlling effect may be
potentiated.

Reduced appetite and anorexia
Reduced appetite and anorexia contribute greatly to CC,
especially during head-and-neck, gastrointestinal, and colorectal cancer (Fredrix et al. 1990). In fact, the disease profile of CC can appear similar to starvation, however, muscle
wasting often precedes decreased energy intake, and can
occur even without anorexia, in both humans and animals
(Tisdale 2001).
Both acute sessions and 12 weeks (3 week−1) of exercise
involving eccentric RET decreased preference and implicit
wanting for sweet foods, but increased preference for fatty
foods (Thivel et al. 2020). This might be particularly beneficial during CC, as patients are urged to consume an energydense diet composed of high amounts of fat (Arends et al.
2021). Equivalent concentric RET increased hunger and
desire to eat more than eccentric, even though both concentric and eccentric RET equally increased total energy consumption (Thivel et al. 2020). Speculatively, due to the lower
energy expenditure of eccentric RET (Lastayo et al. 1999),
the increased energy consumption might result in a higher
net energy balance compared to concentric. These findings
suggest that eccentric might be preferable to concentric RET
in simultaneously increasing preference for energy-dense
foods and energy consumption, however, it is unknown if
this applies during CC.
Regarding endurance training, post-exercise appetite or
ad libitum energy consumption were unchanged after a single session of either LICET or HIIET (Poon et al. 2018).
However, after 16 weeks (5 week−1), both LICET and
HIIET, when combined with RET, increased fasting hunger,
desire to eat, and total energy consumption in adolescents
(Miguet et al. 2020). In another study, 12 weeks (3 week−1)
of either HIIET or LICET increased fasting and postprandial feelings of hunger with no differences between type,
however energy consumption was unchanged (Martins et al.
2017). One possible reason for this discrepancy is that the
second study did not include RET (Martins et al. 2017).
Even though more research is needed, especially during
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CC, these results suggest that a combination of RET and
endurance training might increase hunger and total energy
consumption.

Increased energy expenditure and fat wasting
Despite reduced physical activity, energy expenditure
increases during CC (Fredrix et al. 1990). This hypermetabolic state is thought to occur from a combination of
elevated inflammation and resting lipolysis (Fredrix et al.
1990). When combined with appetite reductions, it inevitably leads to fat and muscle wasting. Apart from being
amplified by the increased energy expenditure, fat wasting
is primarily induced by increased lipolysis, as there is an
increased turnover of free fatty acids and glycerol, caused by
elevated TNF-α (Mathur and Pedersen 2008; Tisdale 2009).
Exercise increases energy expenditure; thus, CC management should include exercise modes that promote muscle
growth with the lowest energy expended.
Endurance training has almost double the energy expenditure compared to RET, when matched for relative intensity
(Bloomer 2005). Moreover, due to its capacity to induce
white adipose tissue browning, mitochondrial biogenesis,
fat loss, and thermogenesis, which are existing problems
during CC (Grgic et al. 2019), LICET is less optimal during CC. Surprisingly, recent reviews recommended endurance training over RET to reduce muscle wasting during CC
(Aquila et al. 2020). However, due to the above-mentioned
contra-indications, LICET may be suboptimal against muscle wasting during CC. Nevertheless, in some cases, even
higher-intensity endurance training modalities of shorter
durations may be beneficial. For example, in mice with CC,
10 weeks of higher-intensity continuous endurance exercise (5 week−1, 30 min/day, 85% VO2max) increased lifespan, reduced tumor mass, and prevented reductions in total
body fat (Bacurau et al. 2007). However, there is a lack of
information on endurance training interspaced with rest on
energy expenditure in CC patients. Interestingly, in healthy
runners replacing LICET with HIIET did not impair aerobic
capacity or muscle oxidative capacity, but decreased energy
expenditure during running (Iaia et al. 2009); however, these
results may differ during CC. Therefore, HIIET could be
beneficial during CC, but priority should be given to RET
when aiming to increase muscle mass with lower energy
expenditure.
Regarding RET types, during eccentric RET the same
muscle work can be produced with only ~ 15% of the metabolic demand, while cardiovascular demand is ~ 40% less
when compared to concentric RET (Lastayo et al. 1999).
These characteristics are attractive for implementation during CC, as eccentric RET can stimulate muscle hypertrophy
but with much lower energy expenditure.
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Insulin resistance, dyslipidemia, and gut dysbiosis
Peripheral insulin resistance (Puppa et al. 2014) and gut
bacteria dysbiosis (Bindels et al. 2016) are common CC
mechanisms. Specifically, myofiber glucose uptake is insulin-dependent via GLUT4, but CC decreases muscle glucose uptake and GLUT4 expression, resulting in peripheral
insulin resistance (Puppa et al. 2014). Additionally, metabolic dysregulation during CC involves lipid metabolism
abnormalities, as indicated by abnormal blood lipid profiles
(dyslipidemia) (Puppa et al. 2014).
A single 30-min low-frequency concentric-only electrical
muscle stimulation session increased muscle GLUT4 mRNA
levels (4.7-fold) in mice with CC, despite being suppressed
by CC at rest (Puppa et al. 2014). Moreover, 6 weeks of
concentric RET (loaded ladder climbing) increased GLUT4
expression in diabetic mice (Dehghan et al. 2016). Several
studies demonstrated that LICET also increases GLUT4
expression in both skeletal and cardiac muscle (Bowman
et al. 2021). Additionally, 6 weeks (3 week−1) of 4–6 sets
of 30-s maximal bicycling increased muscle GLUT4 content by ~ 20% compared to baseline in healthy men (Burgomaster et al. 2007). Despite a lack of information regarding
the effects of long-term exercise on muscle GLUT4 levels
during CC, it appears that exercise modes that rely heavily
on muscle glucose metabolism, such as concentric RET or
endurance training, might be more effective than eccentric
RET in increasing GLUT4 expression.
While the effects of exercise on insulin resistance during CC are unexamined, even a once-per-week (8 weeks),
30-min bout of eccentric RET (knee extensions) improved
resting blood lipid profile (TG − 12.8%, TC − 8.8%, HDL-C
9.3%, LDL-C − 16.4%) and insulin sensitivity (resting glucose − 12%, insulin − 12%, homeostasis model assessment
(HOMA) − 24%, HbA1C − 10.6%) in women, whereas
equivalent concentric RET did not (Paschalis et al. 2011).
Similar improvements were observed with elderly men
after 12 weeks of once-per-week eccentric knee extension RET (resting glucose − 5%, insulin − 24%, HOMA
− 28%, HbA1C − 6%, oral glucose tolerance test − 12%, TG
− 16%, TC − 8%, HDL-C 12%, LDL-C − 7%), and elderly
women after 12 weeks (2 week−1) of downstairs walking
(TG − 20%, TC − 10%, HDL-C 10%, LDL-C − 13%, resting glucose − 9%, insulin − 18%, HOMA − 26%, HbA1C
− 5%, oral glucose tolerance test − 11%), but these findings
were not observed after equivalent concentric exercise (Chen
et al. 2017a, b). These results are promising, and the effects
might be further potentiated with greater weekly frequency
and whole-body programs, however, this needs to be examined during CC.
Although dyslipidemia and insulin resistance are commonly counteracted through nutrition strategies by reducing
body fat, exercise might be a preferable method, especially

during CC. For example, after 12 weeks (3 week−1) of
HIIET in men aiming to improve body composition, there
was a 32% reduction in HOMA, and plasma insulin concentration (− 28%), without reductions in muscle mass (Matinhomaee et al. 2014). However, the group that underwent
only dietary intervention without exercise had decreases
in HOMA (10%) and plasma insulin concentration (12%),
their muscle mass was also significantly decreased (2.2 kg)
(Matinhomaee et al. 2014). Both groups reduced fat mass
as the primary study aim, but it is important to note that CC
patients are already encouraged to consume energy-dense
foods (Arends et al. 2021), which may further dysregulate
their blood lipid profile; thus, attempting to improve blood
lipid profile and insulin resistance through nutrition alone
can be suboptimal due to reductions in energy intake and
muscle loss (Matinhomaee et al. 2014). These studies indicate that nutritional interventions alone are insufficient and
might result in further muscle loss, whereas exercise can
improve CC-induced metabolic dysregulation and muscle
mass.
Gut dysbiosis has been traditionally addressed with nutritional and pharmacological interventions (Bindels et al.
2016), however, regular endurance exercise can confer benefits to gut microbiota. For example, 6 weeks (3 week−1)
of LICET in sedentary women improved gut microbiota
composition and function (Munukka et al. 2018). In another
study, 6 weeks (3 week−1) of LICET in sedentary women
improved gut microbiota composition and function regardless of diet, but those benefits were lost once exercise ceased
(Allen et al. 2018). There is a lack of studies investigating
the effects of RET on gut health, or comparing the effectiveness of LICET and HIIET, especially during CC, however,
exercise seems promising for improving gut dysbiosis.

Hypogonadism
Hypogonadism is the impaired gonad function (testes or
ovaries), resulting in decreased sex hormone production, a
symptom typically observed in both men and women with
CC, with a prevalence of 70% in men with CC (Burney et al.
2012). Hypogonadism during cancer results in a deterioration in muscle mass, quality of life, and survival (Burney
et al. 2012). In fact, blood testosterone levels in both men
and women with CC inversely associate with overall survival
(Bilir et al. 2015). A common method to treat low testosterone levels is testosterone treatment, which improves muscle
mass, quality of life, and physical activity in both men and
women with CC (Wright et al. 2018). However, a study in
elderly hypogonadal men showed that exercise training was
more effective than treatment in increasing aerobic capacity,
and equally effective for muscle growth, leading the authors
to conclude that exercise should be evaluated as an antiaging intervention in preference to therapy (Chasland et al.
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2021). A possible explanation is that testosterone receptor
content in muscle is more important than serum testosterone levels for loading-induced muscle growth (Morton et al.
2018). Overall, there seems to be some evidence to suggest
that testosterone administration alone for hypogonadism and
muscle growth may be suboptimal, as low muscle testosterone receptor content may reduce treatment effectiveness.
Moreover, there could be a role for exercise, when used synergistically with exogenous testosterone.
Despite multiple studies showing the effectiveness of
both eccentric and concentric RET in increasing circulating free testosterone levels shortly after exercise (Kraemer et al. 2006), it is more clinically meaningful to examine resting level changes following long-term training, as
these changes will exert chronic benefits. In a study with
elderly hypogonadal men, 12 weeks of RET (3 week−1) and
LICET increased resting blood testosterone levels (7%), but
this improvement was not statistically significant, whereas
the group that received testosterone therapy had a ~ 25%
increase compared to the placebo group, irrespective of exercising or not (Chasland et al. 2021). Nevertheless, greater
muscle loading increased muscle testosterone receptor content in animals, which in turn could amplify the signaling
potential of circulating testosterone (Lee et al. 2003). This
might explain the similar muscle growth (+ 0.7 kg) observed
in both the exercise-only and the testosterone-only groups
(despite the latter having higher serum testosterone levels),
and the greater muscle growth in the testosterone-plusexercise group (1.4 kg) versus the testosterone-only group
(0.7 kg) (Chasland et al. 2021). These findings suggest that
exercise training can not only increase serum testosterone
but also enhance testosterone signaling potential for muscle growth, possibly through increasing muscle testosterone receptor content. However, the effectiveness of exercise
training in improving hypogonadal status during CC remains
to be examined.

Impaired oxidative capacity and mitochondrial
function
The muscle mitochondrial oxidative pathway, which is
critical for cellular metabolism and growth, is profoundly
impaired during CC by tumor-induced inflammation, leading to fatigue, weakness, and muscle protein breakdown
(VanderVeen et al. 2017). Activation of transcription factors, such as NF-κB and STAT3, in muscle during CC leads
to mitochondrial dysfunction (VanderVeen et al. 2017), and
are relevant as therapeutic targets.
The STAT3 signaling pathway is considered important
for muscle wasting in CC and other conditions with elevated
IL-6, while STAT3 inhibition prevents CC in preclinical cancer models (Bonetto et al. 2012). Long-term eccentric RET
might reduce the activation of STAT3. In mice with CC, only
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2 weeks (4 week−1) of eccentric RET significantly reduced
muscle STAT3 activation (Hardee et al. 2020). However,
if this occurs in the muscles of humans with CC, and if
equivalent concentric RET is similarly effective, remains
uninvestigated.
Regarding NF-κB, in the brain of mice with Parkinson’s
disease, 5 weeks (5 week−1) of loaded ladder climbing
(typical rodent concentric RET protocol) decreased NF-κB
expression (Kim et al. 2021). Moreover, 8 weeks (5 week−1)
of HIIET was more effective than LICET in reducing NF-κB
levels in mouse renal tissue after injury (Leite et al. 2021). In
humans, eccentric RET increased inflammation to a greater
degree than equivalent concentric RET, however repeating
the same session does not trigger the same inflammatory
response. For example, although circulating NF-κB levels
increased after eccentric exercise in elderly men, repeating
the same session after 8 weeks of eccentric lower-limb RET
did not produce any significant changes (Jiménez-Jiménez
et al. 2008). Repeated exercise not only protects against
NF-κB elevations but may actively decrease it. This was
shown in elderly women, where 12 weeks (3 week−1) of
whole-body light-load RET (elastic bands) significantly
reduced serum NF-κB levels (6%) (Roh et al. 2020). Moreover, circulating TLR4 levels (which lead to NF-κB activation and by themselves suppress protein synthesis) were
down-regulated after 6 weeks (3 week−1) of eccentric kneeextension RET in healthy women (Fernandez-Gonzalo et al.
2014), however, there is a lack of information regarding
changes after concentric RET. While these results appear
promising, more research is needed to clarify the effects of
exercise training on muscle NF-κB and STAT3 levels, particularly during CC.
Apart from transcription factors, it is important to examine changes in the final physiological properties of interest, namely mitochondrial content and oxidative capacity.
Although a single 30-min concentric RET session did not
improve mitochondrial biogenesis in mice with severe CC
(Puppa et al. 2014), eccentric RET counteracted the overall
muscle oxidative capacity loss (succinate dehydrogenase
enzyme activity) and improved the distribution of oxidative-rich myofibers (Sato et al. 2019). Moreover, 2 weeks
(4 week−1) of eccentric RET improved muscle oxidative
capacity, and mitochondrial content (increased cytochrome-c
oxidase enzyme activity) in CC muscle (Hardee et al. 2016,
2020), but the effects of concentric RET remain unexamined. Interestingly, increased basal protein synthesis was
positively correlated with increased mitochondrial content
(Hardee et al. 2020). These findings highlight the importance of controlling oxidative capacity and mitochondrial
content in CC muscle for restoring protein synthesis.
It is well known that endurance training can improve
oxidative capacity. Interestingly, only 14 days (6 total sessions) of 4–6 sets of 30-s maximal bicycling induced similar
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improvements to a group that was performing 90–120 min
continuous bicycling in muscle oxidative capacity, buffering capacity (HIIET 7.6% vs LICET 4.2%), and glycogen
content (HIIET 28% vs LICET 17%) (Gibala et al. 2006).
Longer training periods produce similar results, as 6 weeks
(3 week−1) of 4–6 sets of 30-s maximal bicycling induced
similar improvements to a group that was performing
90–120 min continuous bicycling in mitochondrial biogenesis (PGC-1α levels), glycogen content, and oxidative capacity (Burgomaster et al. 2007, 2008). HIIET can produce
similar muscle oxidative capacity and cardiovascular adaptations to LICET but in a more time- and energy-efficient
manner, and thus may be preferable for improving muscle
oxidative capacity and mitochondrial function.
Together, these studies indicate that RET and HIIET
could be tested as an energy-efficient strategy to improve
oxidative capacity and mitochondrial content during
CC, although more research is required to examine this
hypothesis.

Side effects of cancer treatments
Exercise can not only counteract the health effects of CC but
also the side effects of treatments. CC patients are often at
advanced stages of their disease and will undergo multiple
treatments to control cancer progression, but such treatments
can cause serious side effects. As outlined below, several
studies have established the safety and effectiveness of exercise in ameliorating treatment side effects.
Curative cancer treatment often involves surgery, which
can cause further health complications and increase risk for
other conditions. For example, after cancer-related surgeries for lung, prostate, and colorectal cancer, patients have
increased risks of cardiovascular-related events, post-operative complications, and suffer large reductions in muscle
mass and strength (Singh et al. 2017; Ashton et al. 2021).
This can be particularly detrimental during CC, as it further
accelerates muscle wasting, and significantly decreases survival (Choi et al. 2018). Exercise is safe and effective for
improving aerobic exercise capacity, muscle strength, and
health-related quality of life after prostatectomy (Singh et al.
2017; Ashton et al. 2021). For example, 6 weeks (2 week−1)
of RET and 20 min of LICET increased muscle strength
(24%), which was maintained post-surgery (Singh et al.
2017), however, it is impossible to make inferences about its
effectiveness in attenuating the 2.7 kg loss of muscle experienced post-surgery, as there was no non-exercising group. In
a similar study with the inclusion of a non-exercising group,
exercise not only improved endurance exercise capacity
and muscle strength after prostatectomy but also prevented
increases in weight and fat mass occurring in the non-exercising group (Ashton et al. 2021). Systematic reviews have
indicated that pre-surgical exercise for patients with prostate,

lung, colorectal, colon, pancreatic, and bladder cancer may
improve pre- and post-operative physical capacity, muscular
strength, and quality of life, and decrease length of hospital
stay, and post-operative complications (Singh et al. 2017).
Another common cancer-related treatment is chemotherapy which is a particularly critical topic during CC, as not
only does muscle wasting during CC result in greater chemotherapy toxicity and dose reduction, but chemotherapy can
cause CC or exacerbate existing CC (Brierley et al. 2019).
Additionally, chemotherapy results in side effects, such as
low energy, stress, nausea, and pain. Exercise can ameliorate
these negative side effects (Johnsson et al. 2019). Notably,
in women with breast cancer, 26 endurance exercise (both
high- and moderate-intensities) and 31 RET sessions after
chemotherapy onset improved energy and reduced nausea
(Johnsson et al. 2019).
Radiation and hormone therapies are also common and
often combined. Androgen-deprivation therapy decreases
muscle and bone mass, physical function, and causes fatigue
and metabolic syndrome (Galvão et al. 2008; Grossmann
et al. 2011). These side effects are somewhat similar to
the effects of CC, and can collectively increase the risk of
falling, osteoporosis, and bone fractures and compromise
quality of life (Galvão et al. 2008; Grossmann et al. 2011).
Moreover, radiotherapy is commonly performed during
androgen-deprivation therapy and can amplify the negative
side effects of the latter, as radiotherapy can cause muscle
atrophy, fibrosis, and fatigue (Kim et al. 2015). A combination of RET and LICET, performed either 2 or 3 times per
week for 12 weeks prevented muscle loss in prostate cancer patients undergoing androgen-deprivation therapy, even
when combined with radiotherapy (Newton et al. 2021).
Therefore, apart from benefits in health parameters
relevant to CC, another reason to consider incorporating
exercise during CC management is reduced treatment side
effects.

Application and future research directions
MEDLINE and Scopus databases were searched with published studies included until August 2021. Search terms
included various combinations of: cachexia; sarcopenia;
malnutrition; atrophy; muscle wasting; cancer; tumor;
muscle; lean mass; exercise; training; physical activity.
Secondary searches involved reference lists of eligible
articles as well as systematic reviews and meta-analyses
assessing interventions given to patients on ADT. The key
criterion was to identify studies that included patients with
substantial weight loss (≥ 5%) (Fearon et al. 2011) at the
time of intervention, utilizing an exercise or multi-modal
intervention, while including a measure of body mass or
composition. From the identified studies (Table 1), we
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conclude that whole-body RET is safe and effective during
CC, however, it is difficult to draw clear conclusions, as in
half of those studies only some of the participants had CC,
and many studies implemented a multi-modal program of
exercise and nutrition. Nevertheless, a study implemented
6-month (2 week−1) whole-body RET either at home or
performed under supervision in an exercise clinic, and half
of the participants had pancreatic CC (Wiskemann et al.
2019). Even though there was higher adherence with homebased (78.4%) versus clinic-based (64.1%), only the clinicbased group significantly increased upper- and lower-body
strength, and body mass (3.1%). Notably, the RET was of
typical intensity (50–80% of the participant’s maximum
strength) and volume (3 sets; 8–12 repetitions) to induce
muscle hypertrophy in healthy populations (Wiskemann
et al. 2019). In another study, patients with pancreatic CC
underwent 12 weeks (2 week−1) of whole-body RET, similar
to the previous study (50–80% of the participant’s 1-repetition maximum; 3 sets; 8–12 repetitions) (Kamel et al. 2020).
There were improvements in mobility, muscle mass (1–2%),
and strength, of both upper- and lower-limbs compared to a
non-exercising group. Therefore, even higher-intensity (80%
intensity) whole-body RET typically prescribed for healthy
populations is safe and effective during CC and could be
safely implemented in future research.
The information included in this review suggests that
RET (see Fig. 2), and specifically types focusing on the
eccentric portion of the movement, are potentially more tolerable, efficient, and effective in counteracting CC mechanisms, and increasing muscle mass when compared to endurance training. Apart from greater muscle growth at lower
energy costs, eccentric RET is also more time-efficient, as
only 20–30 min of eccentric RET per week can elicit large
increases (> 30%) in muscle size (Mavropalias et al. 2021b).
However, researchers should be aware that unaccustomed
high-intensity eccentric RET can induce muscle soreness,
decreased muscle strength, and increased circulating levels of intramuscular proteins such as creatine kinase (Mavropalias et al. 2021a). Consequently, we recommend that
intensity, in either concentric or eccentric RET, is increased
over several sessions, while submaximal exercise (pre-conditioning) can protect against future higher-intensity exercise (Mavropalias et al. 2020). As eccentric RET appears to
be more specific and potent for counteracting the multiple
causes of wasting at the myofiber level than conventional
or concentric RET, could be very beneficial if incorporated
as an additional brief component after a conventional RET
program.
Moreover, there is unexplored potential of repeated RET
(particularly eccentric) in ‘exploiting’ elevated inflammation to proportionately increase muscle growth. As yet, the
effectiveness of exercise training in improving inflammation, as well as appetite, insulin resistance, dyslipidemia, and
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hypogonadism, in patients with CC remains unexamined.
Further, a combination of RET and HIIET might improve
hunger, total energy consumption, oxidative capacity, mitochondrial content, and gut microbiota composition and function. Well-controlled trials involving patients with CC are
required to answer these research questions.
It is preferable that research projects are conducted in a
clinical setting with appropriate exercise equipment, as it
is otherwise difficult to elicit clinically meaningful muscle
growth with body weight exercises alone, especially when
unsupervised. This was shown in a study where only the
CC patients who underwent supervised whole-body RET
increased upper- and lower-body strength, and body mass
(Wiskemann et al. 2019). While CC patients have lower
muscle strength and exercise capacity compared to healthy
individuals, the exercise principles for muscle growth
must be still adhered to; it is well established that sufficient intensity and volume, and progressive manipulation
of these parameters are required for muscle growth (Grgic
et al. 2019), which may be challenging with light-load or
bodyweight-only exercises. Moreover, adequate supervision
cannot be provided to the same extent during home-based
exercise.
Choosing suboptimal exercise modes can be counterproductive, and could further contribute to CC without impacting muscle growth. For example, LICET can increase energy
expenditure, fat loss, and mitochondrial biogenesis in adipose tissue (Grgic et al. 2019; McKie and Wright 2020), and
although these would be desirable in healthy individuals,
these are CC mechanisms and could exacerbate the disease,
and thus progressive RET should be focused. If progressive
HIIET is incorporated in research, the intensity should be
closer to the higher spectrum of the participant’s individual
exercise capacity (e.g., assessed through perceived effort),
and not ‘high intensity’ as defined based on healthy persons.
Moreover, HIIET should be performed on exercise equipment in which the patient is safely secured, without risking
falls or being unable to stop immediately, such as recumbent
bikes for the lower limbs, and sitting arm cranks or rowing ergometers for the upper limbs. The patient’s perceived
effort, heart rate, and signs of faintness or pain should be
closely monitored by exercise professionals.

Conclusion
Cachexia is a common and devastating symptom of many
chronic conditions. In this review, the multiple disease mechanisms and signs were outlined and these are often complementary and amplify one another. Additionally, evidence
from the available literature indicates that exercise therapy
could potentially counteract most of the CC mechanisms
and side effects from cancer-related treatments commonly
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Fig. 2  Reversal of the cachexia feedback loop by targeted resistance-based exercise training. CRP C-reactive protein, IGF-1 insulin growth factor
1, IL interleukin, TGF-β transforming growth factor beta, TNF-α tumor necrosis factor alpha

administered during CC. Prevention and early treatment
of CC have been extensively recommended (Fearon et al.
2011), but in many cases, prevention is not possible, as the
patient is already in mid-CC when diagnosed (Fearon et al.
2011), highlighting the need for more trials in advanced CC
stages. To date, most of the available evidence is limited
to animal models of CC or healthy humans, although this
still provides valuable information. Nevertheless, the available evidence is still limited, while exercise during CC has

been discouraged (Roeland et al. 2020), despite its success
in increasing muscle and body mass in humans with particularly aggressive CC forms (Lønbro et al. 2013a; Naito
et al. 2019; Wiskemann et al. 2019; Kamel et al. 2020). As
a result, there is an urgent need for human trials to examine
the effectiveness of RET in counteracting CC mechanisms
and increasing muscle mass.
As outlined in the sections above, due to the increased
energy expenditure, adipose tissue mitochondrial biogenesis,
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and muscle wasting typically observed during CC, LICET is
discouraged, and instead different forms of RET should be
investigated to determine their effectiveness in counteracting muscle wasting but adjusted to the needs and capacity
of the patient. Regarding specific RET types, eccentric RET
appears promising in increasing protein synthesis regardless of elevated inflammation, resulting in muscle growth at
lower energy costs. However, even conventional eccentric/
concentric RET, when progressively increased in volume
and intensity, is a potent, easily accessible, low-cost, and
safe therapy for research in the management of CC-induced
muscle wasting.
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